Balapadang, R. N. and Sudarjat, H. (2024) “Potential of Beta-Hydroxybutyrate (BHB) in the Management of Type 2 Diabetes and Risk of Ketoacidosis in Diabetic Patients”, Journal of Pharmaceutical and Sciences, 7(4), pp. 562–570. doi: 10.36490/journal-jps.com.v7i4.520.